CORD-19:867ebb2be2d466bcb35e5a7319708eaff39c4799 / 158863-159261 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T108","span":{"begin":0,"end":15},"obj":"Sentence"},{"id":"T109","span":{"begin":16,"end":398},"obj":"Sentence"}],"text":"The Background: Diclofenac, one of non-steroidal anti-inflammatory drugs (NSAIDs), was reported to be associated with the alleviation in the severity of Clostridium difficile infection (CDI), due to its inhibitory effect on phospholipase A2 and cyclooxygenase-2 (Cox-2), which play important roles in disruption of epithelial integrity and gut inflammatory response induced by C. difficile toxin A."}

{"project":"CORD-19-Sentences","denotations":[{"id":"T48776","span":{"begin":0,"end":15},"obj":"Sentence"},{"id":"T48494","span":{"begin":16,"end":398},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The Background: Diclofenac, one of non-steroidal anti-inflammatory drugs (NSAIDs), was reported to be associated with the alleviation in the severity of Clostridium difficile infection (CDI), due to its inhibitory effect on phospholipase A2 and cyclooxygenase-2 (Cox-2), which play important roles in disruption of epithelial integrity and gut inflammatory response induced by C. difficile toxin A."}

{"project":"Epistemic_Statements","denotations":[{"id":"T261","span":{"begin":0,"end":398},"obj":"Epistemic_statement"}],"text":"The Background: Diclofenac, one of non-steroidal anti-inflammatory drugs (NSAIDs), was reported to be associated with the alleviation in the severity of Clostridium difficile infection (CDI), due to its inhibitory effect on phospholipase A2 and cyclooxygenase-2 (Cox-2), which play important roles in disruption of epithelial integrity and gut inflammatory response induced by C. difficile toxin A."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T886","span":{"begin":153,"end":184},"obj":"Disease"},{"id":"T887","span":{"begin":175,"end":184},"obj":"Disease"},{"id":"T888","span":{"begin":186,"end":189},"obj":"Disease"},{"id":"T876","span":{"begin":153,"end":184},"obj":"Disease"},{"id":"T6821","span":{"begin":175,"end":184},"obj":"Disease"},{"id":"T7198","span":{"begin":186,"end":189},"obj":"Disease"}],"attributes":[{"id":"A886","pred":"mondo_id","subj":"T886","obj":"http://purl.obolibrary.org/obo/MONDO_0000705"},{"id":"A887","pred":"mondo_id","subj":"T887","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A888","pred":"mondo_id","subj":"T888","obj":"http://purl.obolibrary.org/obo/MONDO_0015790"},{"id":"A889","pred":"mondo_id","subj":"T888","obj":"http://purl.obolibrary.org/obo/MONDO_0000705"},{"id":"A17475","pred":"mondo_id","subj":"T876","obj":"http://purl.obolibrary.org/obo/MONDO_0000705"},{"id":"A93455","pred":"mondo_id","subj":"T6821","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A88083","pred":"mondo_id","subj":"T7198","obj":"http://purl.obolibrary.org/obo/MONDO_0015790"},{"id":"A92364","pred":"mondo_id","subj":"T7198","obj":"http://purl.obolibrary.org/obo/MONDO_0000705"}],"text":"The Background: Diclofenac, one of non-steroidal anti-inflammatory drugs (NSAIDs), was reported to be associated with the alleviation in the severity of Clostridium difficile infection (CDI), due to its inhibitory effect on phospholipase A2 and cyclooxygenase-2 (Cox-2), which play important roles in disruption of epithelial integrity and gut inflammatory response induced by C. difficile toxin A."}